Source: Bmc cancer. Unidade: FM
Subjects: ENVELHECIMENTO, BIOMARCADORES, MEIA IDADE, ESTUDOS RETROSPECTIVOS, TAXA DE SOBREVIVÊNCIA, LINFOMA
ABNT
GOUVEIA, Gisele Rodrigues et al. Overexpression of OCT-1 gene is a biomarker of adverse prognosis for diffuse large B-cell lymphoma (DLBCL): data from a retrospective cohort of 77 Brazilian patients. Bmc cancer, v. 20, n. 1, 2020Tradução . . Disponível em: https://doi.org/10.1186/s12885-020-07553-2. Acesso em: 02 nov. 2024.APA
Gouveia, G. R., Ferreira, S. C., Siqueira, S. A. C., Lage, L. A. de P. C., Hallack Neto, A. E., Costa, R. de O., & Pereira, J. (2020). Overexpression of OCT-1 gene is a biomarker of adverse prognosis for diffuse large B-cell lymphoma (DLBCL): data from a retrospective cohort of 77 Brazilian patients. Bmc cancer, 20( 1). doi:10.1186/s12885-020-07553-2NLM
Gouveia GR, Ferreira SC, Siqueira SAC, Lage LA de PC, Hallack Neto AE, Costa R de O, Pereira J. Overexpression of OCT-1 gene is a biomarker of adverse prognosis for diffuse large B-cell lymphoma (DLBCL): data from a retrospective cohort of 77 Brazilian patients [Internet]. Bmc cancer. 2020 ; 20( 1):[citado 2024 nov. 02 ] Available from: https://doi.org/10.1186/s12885-020-07553-2Vancouver
Gouveia GR, Ferreira SC, Siqueira SAC, Lage LA de PC, Hallack Neto AE, Costa R de O, Pereira J. Overexpression of OCT-1 gene is a biomarker of adverse prognosis for diffuse large B-cell lymphoma (DLBCL): data from a retrospective cohort of 77 Brazilian patients [Internet]. Bmc cancer. 2020 ; 20( 1):[citado 2024 nov. 02 ] Available from: https://doi.org/10.1186/s12885-020-07553-2